—Õ�°–òŠw

 

’˜�@�‘

 

1)         �¼Œû�HŽi: ˆã—ÖòŠw. ‘æ5”Å, –x�@—¹•½�@ŠÄ�C, Š£�@Œ«ˆê‚ç�@•Ò�W, œA�ì�‘“X (2009).

 

2)         �¼Œû�HŽi: ŽÀ–±ŽÀ�KŽ–‘OŠw�K‚Ì‚½‚߂̒²�ÜŠw, ŽÄ�è�³�Ÿ‚ç�@ŠÄ�C, Œú“c�Kˆê˜Y‚ç�@•Ò�W, œA�ì�‘“X (2009).

 

3)         �¼Œû�HŽi: ƒVƒiƒŠƒI�Ç—á‰ð�Í -ˆã—Â̌»�ê‚Å�¡�c-, �‚ŽR�@–¾�@•Ò�W, œA�ì�‘“X (2009).

 

˜_�@•¶

 

1)         Marie Nagai, Takahiro Fukamachi, Masayuki Tsujimoto, Kenichiro Ogura, Akira Hiratsuka, Hisakazu Ohtani, Satoko Hori, Yasufumi Sawada: Inhibitory effects of herbal extracts on the activity of human sulfotransferase isoform sulfotransferase 1A3 (SULT1A3). Biol. Pharm. Bull., 32, 105-109 (2009). 

 

2)         ú㌴�»Žq, ŽR�XŒ³”Ž, ’†‘º�@”C, �¼Œû�HŽi, ‰œ–ì’B�Æ, ’ƒ‰®Œ´�Ø•äŽq, ŽO–Ø�¶–ç, “c‘º�F—Y, •½ˆä‚݂ǂè, •Љª˜aŽO˜Y, ‰h“c•q”V: �H“¹‚ª‚ñ‰»Šw•úŽË�ü—Ö@‚É‚¨‚¯‚é5-ƒtƒ‹ƒIƒ�ƒEƒ‰ƒVƒ‹ŒŒŸ÷’†”Z“x‚Æ•›�ì—p‚Æ‚Ì‘ŠŠÖ. TDMŒ¤‹†, 26, 7-13 (2009).

 

3)         Sayo Horibe, Kohji Takara, Tetsuya Minegaki, Noriaki Ohnishi, Teruyoshi Yokoyama: Distribution of ABCG2 (BCRP) and ABCC2 (MRP2) mRNAs in rat small intestine and liver. EXCLI Journal, 8, 12-19 (2009).

 

4)         •õŠ_“N–ç, �¬—Ñ�@–r, �V�@�NŒ›, –k“c“¿�º, �X“c‘�Žq, ‹g‰ª–r“W, ’Ò�@—²Žu, “n�@‰ë�Ž, •�“¡�r•F, �£”ö�@“O: •ó’ËŽs—§•a‰@‚É‚¨‚¯‚é‰@“à�»�܃uƒ��[Ž�‰t‚Ì—Õ�°Žg—pŒoŒ±. ލ•@‚Æ—Õ�°, 55, 26-30 (2009).

 

5)         Jahye Kim, Hisakazu Ohtani, Masayuki Tsujimoto, Yasufumi Sawada: Quantitative comparison of the convulsive activity of combinations of twelve fluoroquinolones with five nonsteroidal anti-inflammatory agents. Drug Metab. Pharmacokinet., 24, 167-174 (2009).

 

6)         Fumiaki Kitazawa, Toshio Abe, Kumi Ueda, Satoshi Murakami, Kohshi Nishiguchi, Kohji Takara, Teruyoshi Yokoyama, Hikofumi Sugii: Relation of age with myelosuppression induced by the CHOP regimen in patients with Non-Hodgkin�fs Lymphoma. Cancer Therapy, 7, 133-140 (2009).

 

7)         Masayuki Tsujimoto, Maya Horie, Hiroko Honda, Kohji Takara, Kohshi Nishiguchi: The structure-activity correlation on the inhibitory effects of flavonoids on cytochrome P450 3A activity. Biol. Pharm. Bull., 32, 671-676 (2009).

 

8)         Tsutomu Nakamura, Noboru Okamura, Mariko Yagi, Hideki Omatsu, Motohiro Yamamori, Akiko Kuwahara, Kohshi Nishiguchi, Masanori Horinouchi, Katsuhiko Okumura, Toshiyuki Sakaeda: Effects of ABCB1 3435C>T genotype on serum levels of cortisol and aldosterone in women with normal menstrual cycles. Genet. Mol. Res., 8, 397-403 (2009).

 

9)         Kyohei Shintaku, Satoko Hori, Masayuki Tsujimoto, Hideaki Nagata, Shoji Satoh, Kiyomi Tsukimori, Hitoo Nakano, Tomoyuki Fujii, Yuji Taketani, Hisakazu Ohtani, Yasufumi Sawada: Transplacental pharmacokinetics of diclofenac in perfused human placenta. Drug Metab. Dispos., 37, 962-968 (2009).

 

10)     Kohji Takara, Noriaki Kitada, Eri Yoshikawa, Kazuhiro Yamamoto, Sayo Horibe, Toshiyuki Sakaeda, Kohshi Nishiguchi, Noriaki Ohnishi, Teruyoshi Yokoyama: Molecular changes to HeLa cells on continuous exposure to SN-38, an active metabolite of irinotecan hydrochloride. Cancer Lett., 278, 88-96 (2009).

 

11)     Akiko Kuwahara, Motohiro Yamamori, Kohshi Nishiguchi, Tatsuya Okuno, Naoko Chayahara, Ikuya Miki, Takao Tamura, Tsubasa Inokuma, Yoshiji Takemoto, Tsutomu Nakamura, Kazusaburo Kataoka, Toshiyuki Sakaeda: Replacement of cisplatin with nedaplatin in a definitive 5-fluorouracil/cisplatin-based chemoradiotherapy in Japanese patients with esophageal squamous cell carcinoma. Int. J. Med. Sci., 6, 305-311 (2009).

 

12)     –k“c“¿�º, �¼–ì‰ë�s, ˆÀ“c�@��, �X“c‘�Žq, “¡ˆä�ç‰ê, •õŠ_“N–ç, ‹ß“¡–œ—F”ü, ˆ¢“ì�ߎq, �‚—Ç�PŽj, “n�@‰ë�Ž: ˆê”Ê•a‰@‚É‚¨‚¯‚é“û‚ª‚ñ‰»Šw—Ö@‚̋ςĂñ‰»‚ð‚ß‚´‚µ‚Ä (‘æ2•ñ�j-FEC‚¨‚æ‚ÑTC—Ö@‚É‚¨‚¯‚éˆÀ‘S�«‚ÌŒŸ“¢-. Šà‚Ɖ»Šw—Ö@, 36, 1671-1675 (2009).

 

 

 

‘��@�à

 

1)           Toshiyuki Sakaeda, Motohiro Yamamori, Akiko Kuwahara, Kohshi Nishiguchi: Pharmacokinetics and pharmacogenomics in esophageal cancer chemoradiotherapy. Adv. Drug Deliv. Rev., 61, 388-401(2009).

 

Šw‰ï”­•\“™

 

�@�@�@Šw‰ï”­•\

 

1)       “°‰º�^—œ, �¬’r”ü��, –å˜e—SŽq, ‰Ô–[‰Á“ÞŒb, ŒÜ•S‘ •�Žm, ˜a“c�@“Ö, ŠpŽR���D, ê –{”Ž—Y, �¼Œû�HŽi, •½ˆä‚݂ǂè: ˆÀ‘S‚ÈŠO—ˆ‰»Šw—Ö@‚É‚¨‚¯‚é–ò�ÜŽt‚Ì–ðŠ„‚É‚Â‚¢‚Ä, ‘æ30‰ñ“ú–{•a‰@–ò�ÜŽt‰ï�@‹ß‹EŠw�p‘å‰ï (‘å�ã), 2009. 1. 24-25.

 

2)       �a’J“Þ•ä, �…“c’¼”ü, �A“c‹MŽj, ‘å�¼�G–¾, ŽR‰º˜a•F, ŠpŽR���D, ê –{”Ž—Y, �¼Œû�HŽi, •½ˆä‚݂ǂè, �r�ì‘nˆê, Šâ“cŒ’‘¾˜Y: Žè�p•”ƒTƒeƒ‰ƒCƒg–ò‹Ç‚̉^—p‚ÆŽè�p’†‚Ì�R‹Û–òŽg—p•û–@‚Ì“K�³‰», ‘æ30‰ñ“ú–{•a‰@–ò�ÜŽt‰ï�@‹ß‹EŠw�p‘å‰ï (‘å�ã), 2009. 1. 24-25.

 

3)       �¬–ì—R‰Á—¢, �A“c‹MŽj, “c’†Œ’‘¾, ŽR�XŒ³”Ž, Šp–{в•v, ŠpŽR���D, ê –{”Ž—Y, �¼Œû�HŽi, •½ˆä‚݂ǂè: ƒ^ƒNƒ�ƒŠƒ€ƒXŒŒ’†”Z“x‘ª’è‚É‚¨‚¯‚éACMIA–@‚ÆMEIA–@‚Ì”äŠr, ‘æ30‰ñ“ú–{•a‰@–ò�ÜŽt‰ï�@‹ß‹EŠw�p‘å‰ï (‘å�ã), 2009. 1. 24-25.

 

4)       �A“c‹MŽj, Šp–{в•v, ŽR�XŒ³”Ž, ŠpŽR���D, ê –{”Ž—Y, �¼Œû�HŽi, •½ˆä‚݂ǂè: �tˆÚ�AгŽÒ‚É‚¨‚¯‚éƒ^ƒNƒ�ƒŠƒ€ƒX‚ƃvƒ�ƒgƒ“ƒ|ƒ“ƒv‘jŠQ�܂̖ò•¨‘ŠŒÝ�ì—p, ‘æ30‰ñ“ú–{•a‰@–ò�ÜŽt‰ï�@‹ß‹EŠw�p‘å‰ï (‘å�ã), 2009. 1. 24-25.

 

5)       ŠÛŽR“Þ•ä, ŠpŽR���D, Šp–{в•v, ê –{”Ž—Y, �¼Œû�HŽi, •½ˆä‚݂ǂè: ƒwƒpƒŠƒ“‹Nˆö�«ŒŒ�¬”ÂŒ¸�­�Ç(HIT)‚ÉŠÖ‚·‚éˆã—Ã�]Ž–ŽÒ‚Ì”Fޝ“x’²�¸, “ú–{–òŠw‰ï‘æ129”N‰ï (‹ž“s), 2009. 3. 26-28.

 

6)       �ã“c�C•½, �웽�´��, ‘�Œ©‹±Žq, ‘º“c�¬”Í, –؉ºŒ’Ži, ‹g“c–¾�O, Šp–{в•v, �¼Œû�HŽi, •½ˆä‚݂ǂè: ƒ�ƒ‹ƒtƒ@ƒŠƒ“ŽŠ“K“Š—^—ÊŒˆ’è‚É‚¨‚¯‚éASP-PCR–@‚ð—p‚¢‚½ˆâ“`ŽqŒ^”»’è‚Ì—L—p�«, “ú–{–òŠw‰ï‘æ129”N‰ï (‹ž“s), 2009. 3. 26-28.

 

 

7)       ŽR–{˜a�G, Œ´�@Œ«‘¾, ‰i“c�³’j, �‚—Ç�PŽj, �¼Œû�HŽi, •½ˆä‚݂ǂè, ‰¡–ì�_ˆê: ƒ‰ƒpƒ}ƒCƒVƒ“•W“Iƒ^ƒ“ƒpƒNŽ¿(mTOR)ƒVƒOƒiƒ‹“`’BŒn‚̉h—{Š´’mƒVƒXƒeƒ€‚Æ‚µ‚Ä‚Ì–ðŠ„‚Æ‚»‚Ì•ªŽqƒ�ƒJƒjƒYƒ€, “ú–{–òŠw‰ï‘æ129”N‰ï (‹ž“s), 2009. 3. 26-28.

 

8)       –{“c�hŽq, ’Ò–{‰ë”V, �¬�ì”ü•äŽq, ‘�“c‰À‘ãŽq, ‰ª–{ŠG—¢��, �¬–ì�¹�K, �‚—Ç�PŽj, �¼Œû�HŽi: –ò•¨‚Ì�Á‰»ŠÇ–Œ“§‰ß�«‚É‹y‚Ú‚·ŠeŽíˆù—¿Ž�‘±”˜˜I‚̉e‹¿, “ú–{–òŠw‰ï‘æ129”N‰ï (‹ž“s), 2009. 3. 26-28.

 

9)       ’Ò–{‰ë”V: “§�ÍŠ³ŽÒ‚É‚¨‚¯‚é�tŠOƒNƒŠƒAƒ‰ƒ“ƒX‚̕ϓ®�GƒVƒ“ƒ|ƒWƒEƒ€13�u“§�͂ɂ¨‚¯‚é–ò•¨“Š—^‚Ì–â‘è“_�v�C‘æ54‰ñ“ú–{“§�͈ãŠw‰ïŠw�p�W‰ï�E‘�‰ï (‰¡•l)�C2009. 6. 5-7.

 

10)    ‰¡“c�lŽm, ’Ò–{‰ë”V, ”µ›½‘å‰î, �´�…–ƒ—�Œb, ŽR–{�_Žj, �™–{ŽÑ—œ, ’·—F–ƒ‹KŽq, •õŠ_“N–ç, �‚—Ç�PŽj, �¼Œû�HŽi: –��«�t•s‘Sƒ‚ƒfƒ‹ƒ‰ƒbƒg‚É‚¨‚¯‚é–ò•¨ƒgƒ‰ƒ“ƒXƒ|�[ƒ^�[‚Ì‘g�D“ÁˆÙ“I‚È”­Œ»•Ï“®, ˆã—ÖòŠwƒtƒH�[ƒ‰ƒ€2009�^‘æ17‰ñƒNƒŠƒjƒJƒ‹ƒtƒ@�[ƒ}ƒV�[ƒVƒ“ƒ|ƒWƒEƒ€ (‹ž“s) �C2009. 7. 11-12.

 

11)    –{“c�hŽq, ’Ò–{‰ë”V, ‘�“c‰À‘ãŽq,  �¬�ì”ü•äŽq, ‰ª–{ŠG—¢��, �‚—Ç�PŽj, �¼Œû�HŽi: �Á‰»ŠÇ‚É‚¨‚¯‚é–ò•¨ƒgƒ‰ƒ“ƒXƒ|�[ƒ^�[‚É‹y‚Ú‚·ƒtƒ‰ƒ{ƒmƒCƒhŠÜ—Lˆù—¿‚ÌŽ�‘±”˜˜I‚̉e‹¿, ˆã—ÖòŠwƒtƒH�[ƒ‰ƒ€2009�^‘æ17‰ñƒNƒŠƒjƒJƒ‹ƒtƒ@�[ƒ}ƒV�[ƒVƒ“ƒ|ƒWƒEƒ€ (‹ž“s), 2009. 7. 11-12.

 

12)    ‰¡“c�lŽm, ’Ò–{‰ë”V, �™–{ŽÑ—œ, ’·—F–ƒ‹KŽq, •õŠ_“N–ç, �¼Œû�HŽi: �t•s‘S�i�sˆöŽq‚Å‚ ‚éƒCƒ“ƒhƒLƒVƒ‹—°Ž_‚Ì�Á‰»ŠÇ“®‘Ԃ̉ð–¾, ‘æ3‰ñ“ú–{�t‚Æ–ò�ÜŒ¤‹†‰ïŠw�p‘å‰ï2009 (–¼ŒÃ‰®), 2009. 9. 19-20.

 

13)    åM“c’¼Šó, �‚—Ç�PŽj, •õŠ_“N–ç, –k“c“¿�º, ’Ò–{‰ë”V, �¼Œû�HŽi, ‰¡ŽR�Æ—R: –Ô—…“Iˆâ“`Žq”­Œ»‰ð�͂Ɋî‚¢‚½�RŽîá‡�«”’‹à�ö‘ÌŠ´Žó�«ˆöŽq‚Ì’T�õ, ‘æ19‰ñ“ú–{ˆã—ÖòŠw‰ï”N‰ï (’·�è), 2009. 10. 24-25.

 

14)    Hiroko Honda, Masayuki Tsujimoto, Erika Okamoto, Tetsuya Minegaki, Kohshi Nishiguchi: Effects of continuous ingestion of grapefruit juice on the intestinal absorption of fexofenadine in mice, 24th JSSX Annual Meeting in Kyoto, 2009. 11. 27-29.

 

15)    Daisuke Shima, Masayuki Tsujimoto, Shima Hiraoka, Ayaka Miyoshi, Tetsuya Minegaki, Kohshi Nishiguchi: Mechanism for decreased digoxin concentration by fexofenadine in hemodialysis patients, 24th JSSX Annual Meeting in Kyoto, 2009. 11. 27-29.

 

�@�@�@�u‰‰“™

 

1)         �¼Œû�HŽi: ‹ž“s–ò‰È‘åŠwƒI�[ƒvƒ“ƒLƒƒƒ“ƒpƒX, ƒ~ƒj�u‹` (‹ž“s), 2009. 8.

 

2)         �¼Œû�HŽi: �_ŒË–ò‰È‘åŠw‘åŠw‰@�u‹`, ƒtƒ@�[ƒ}ƒVƒ…�[ƒeƒBƒJƒ‹ƒPƒA“Á˜_ (�_ŒË), 2009. 11.

 

3)         �¼Œû�HŽi, ’Ò–{‰ë”V, •õŠ_“N–ç: ‹ž“s–ò‰È‘åŠwˆê”ÊŒöŠJ�u�À, ƒ|ƒXƒ^�[Œfަ (‹ž“s), 2009. 11.

 

�@�@�@‚»‚Ì‘¼

 

1)           �¼Œû�HŽi: ŽQ‰Á. ‹ž“s–ò‰È‘åŠw�E‹ž“s•{•a‰@–ò�ÜŽt‰ï�@˜AŒgƒ��[ƒNƒVƒ‡ƒbƒv (‹ž“s), 2009. 1.

 

2)           �¼Œû�HŽi: ŽQ‰Á. ‹ž“s•{–ò�ÜŽt‰ï�E‹ž“s•{•a‰@–ò�ÜŽt‰ï�@ŽÀ–±ŽÀ�KŽó“ü˜A—�‰ï (‹ž“s), 2009. 8.

 

3)           �¼Œû�HŽi: ˆÏˆõ, ‰Û‘è�Ó”CŽÒ, ‘�Ї. ‹ž“s–ò‰È‘åŠw�@–òŠw‹¤—pŽŽŒ±OSCE (‹ž“s), 2009. 12.

 

4)           ’Ò–{‰ë”V: ‰Û‘è�Ó”CŽÒ. ‹ž“s–ò‰È‘åŠw�@–òŠw‹¤—pŽŽŒ±OSCE (‹ž“s), 2009. 12.

 

5)           •õŠ_“N–ç: ƒXƒ^ƒbƒtƒ`�[ƒt. ‹ž“s–ò‰È‘åŠw�@–òŠw‹¤—pŽŽŒ±OSCE (‹ž“s), 2009. 12.

 

6)           �¼Œû�HŽi, ’Ò–{‰ë”V, •õŠ_“N–ç: •]‰¿ŽÒ. “¯ŽuŽÐ�—Žq‘åŠw�@–òŠw‹¤—pŽŽŒ±OSCE (‹ž“s), 2009. 12.